Periprocedural Factor Xa Inhibitor Interruption and Resumption for Patients With Atrial Fibrillation Undergoing Dental Procedures
Korean Circulation Journal · 2026 · 56 (11) · 1064
DOI: 10.4070/kcj.2025.0429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Korean Circulation Journal, 2026. Verfasst von Kyung-Yeon Lee und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Samjinpharm, National Research Foundation of Korea, Patient-Centered Clinical Research Coordinating Center.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVES: In the PERIXa study, a standardized periprocedural interruption protocol for factor Xa (FXa) inhibitors led to very low major bleeding rates and no thromboembolic events among patients undergoing procedures with minimal to low bleeding risk. However, dental procedures showed the highest all-bleeding rate. This sub-analysis assessed bleeding outcomes by dental procedure type, FXa inhibitor, and dosing regimen to inform tailored anticoagulation strategies in dental practice. METHODS: This analysis included atrial fibrillation (AF) patients from PERIXa who underwent dental procedures managed with a standardized FXa inhibitor interruption protocol. All-bleeding events-comprising major, clinically relevant non-major, and minor bleeding-as well as thromboembolic events and all-cause death, were evaluated within 30 days. Intraoperative bleeding severity was reported by dentists using standardized questionnaires. RESULTS: Among 820 patients (mean age 71.3 ±9.4 years; 42.0% female) undergoing dental procedures with periprocedural direct oral anticoagulant (DOAC) interruption per the PERIXa protocol, the overall all-bleeding rate was 5.0%, with major bleeding occurring in only 0.2%. No thromboembolic events or deaths were reported. Bleeding risk did not differ significantly by procedure type, DOAC agent, or regimen, though numerically higher all-bleeding rates were observed with implants and combined procedures. Most dentists reported no or manageable bleeding, with no significant variation across groups. CONCLUSIONS: Dental procedures performed under the PERIXa protocol were associated with low bleeding risk and excellent thromboembolic safety. These findings support the applicability of the protocol across various dental interventions and DOAC regimens in patients with AF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Department of Cardiology, Dong-A University Hospital, Busan, Korea.
- Department of Cardiology, Daegu Catholic University Medical Center, Daegu, Korea.
- Department of Cardiology, St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
ORCID-Profile: Kyung-Yeon Lee, So-Ryoung Lee, Jong-Sung Park, Yong Seog Oh, June Namgung, Ji Hyun Lee, Woo-Hyun Lim, Min Soo Ahn, Soonil Kwon, Hyo-Jeong Ahn, Seil Oh, Gregory Y H Lip, Eue-Keun Choi
Förderung
- Samjinpharm
- National Research Foundation of Korea
- Patient-Centered Clinical Research Coordinating Center
Zitieren
APA
Lee, K. Y., Lee, S. R., Park, J. S., Lee, Y. S., Oh, Y. S., Han, S. J., Namgung, J., Lee, J. H., Lim, W. H., Ahn, M. S., Kwon, S., Ahn, H. J., Oh, S., Lip, G. Y. H., Choi, E. K., & PERIXa Investigators (2026). Periprocedural Factor Xa Inhibitor Interruption and Resumption for Patients With Atrial Fibrillation Undergoing Dental Procedures. Korean Circulation Journal, 56(11), 1064. https://doi.org/10.4070/kcj.2025.0429
Vancouver
Lee KY, Lee SR, Park JS, Lee YS, Oh YS, Han SJ, et al. Periprocedural Factor Xa Inhibitor Interruption and Resumption for Patients With Atrial Fibrillation Undergoing Dental Procedures. Korean Circulation Journal. 2026;56(11):1064. doi:10.4070/kcj.2025.0429
BibTeX
@article{Lee2026,
author = {Lee, Kyung-Yeon and Lee, So-Ryoung and Park, Jong-Sung and Lee, Young Soo and Oh, Yong Seog and Han, Sang-Jin and Namgung, June and Lee, Ji Hyun and Lim, Woo-Hyun and Ahn, Min Soo and Kwon, Soonil and Ahn, Hyo-Jeong and Oh, Seil and Lip, Gregory Y H and Choi, Eue-Keun and PERIXa Investigators, PERIXa Investigators},
title = {Periprocedural Factor Xa Inhibitor Interruption and Resumption for Patients With Atrial Fibrillation Undergoing Dental Procedures},
journal = {Korean Circulation Journal},
year = {2026},
volume = {56},
number = {11},
pages = {1064},
doi = {10.4070/kcj.2025.0429}
}
EUVIMED